Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HIV

Finding latent needles in a haystack

Nature volume 543, pages 499–500 (2017)Cite this article

Subjects

Antiretroviral therapy can keep HIV at bay, but a few cells remain infected, so the disease cannot be cured. The discovery of a protein that marks out these infected cells will facilitate crucial studies of this latent viral reservoir. See Letter p.564

The development of combination antiretroviral therapy, which suppresses the replication of HIV in immune-system cells called CD4 T lymphocytes, is a major achievement of modern medicine1. However, a small proportion of these CD4 T cells retains the virus despite ongoing therapy, forming a latent HIV reservoir that can reactivate if treatment is stopped. Ways of eradicating this reservoir are an intense focus of research, but efforts have been hampered by the difficulty of analysing latently infected cells — of the order of one in a million CD4 T cells in an individual receiving antiretroviral therapy is latently infected, and markers for these cells have been lacking2,3. On page 564, Descours et al.4 have identified just such a marker for about half of the latently infected CD4 T cells in the blood.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1: Hunting down an elusive cell population.

Notes

  1. See all news & views

References

  1. http://www.who.int/hiv/data/en/

  2. Haase, A. T. Annu. Rev. Immunol. 17, 625–656 (1999).

    Article  CAS  Google Scholar 

  3. Richman, D. D. et al. Science 323, 1304–1307 (2009).

    Article  CAS  ADS  Google Scholar 

  4. Descours, B. et al. Nature 543, 564–567 (2017).

    Article  CAS  ADS  Google Scholar 

  5. Han, Y. et al. Nature Rev. Microbiol. 5, 95–106 (2007).

    Article  CAS  Google Scholar 

  6. Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H. & Lambrecht, B. N. Nature Rev. Immunol. 14, 94–108 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Douglas D. Richman is at the Center for AIDS Research, University of California San Diego, La Jolla, California 92093–0679, USA, and at the Veteran Affairs San Diego Healthcare System, San Diego.,

    Douglas D. Richman

Authors
  1. Douglas D. Richman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas D. Richman.

Related audio

Related links

Related links

Related links in Nature Research

HIV: Cure by killing

HIV: Seeking ultimate victory

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Richman, D. Finding latent needles in a haystack. Nature 543, 499–500 (2017). https://doi.org/10.1038/nature21899

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature21899

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing